Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

12.93
Delayed Data
As of Jan 13
 +0.11 / +0.86%
Today’s Change
10.52
Today|||52-Week Range
19.98
+5.38%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close12.82
Today’s open12.90
Day’s range12.90 - 13.28
Volume982,621
Average volume (3 months)1,660,889
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-78.92%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book272.10

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+1.26+2.85%
EXASExact Sciences Corp-0.03-0.16%
JUNOJuno Therapeutics In...+0.33+1.68%
ONCESpark Therapeutics I...-0.16-0.28%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs